ConductScience.org, home

Paper4333399

1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture.

Raisz LG and 3 others. Science, 1972. Cited by 589 papers, by iCite.

Cite this record

ConductScience Library. 1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Papers, record 4333399. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4333399

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture.
PubMed
Journal
Science
PubMed
Year
1972
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
589
iCite
Relative citation ratio, by iCite
17.7
iCite
Revised in PubMed
2019-06-18
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Raisz LGL G
2Trummel CLC L
3Holick MFM F
4DeLuca HFH F

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone ResorptionMajor topic
CholecalciferolMajor topic
Animals
Autoradiography
Bone and Bones
Calcium
Calcium Isotopes
Culture Techniques
Hydroxycholecalciferols
Kidney
Rats
Stimulation, Chemical
Tritium

Source PubMed

Download CSV of topics

Cited by133

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 589 citations.

PMIDTitleJournalYearIn PapersSource
41828612Vitamin D Receptor Signaling and Ligand Modulation: Molecular Mechanisms and Therapeutic Implications.Int J Mol Sci2026https://conductscience.org/library/papers/41828612PubMed
39683587Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy.Nutrients2024https://conductscience.org/library/papers/39683587PubMed
38102330Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report.Osteoporos Int2024https://conductscience.org/library/papers/38102330PubMed
35967790Quantification of Vitamins, Minerals, and Amino Acids in Black Walnut (Juglans nigra).Front Nutr2022https://conductscience.org/library/papers/35967790PubMed
33657451Natural medicine delivery from biomedical devices to treat bone disorders: A review.Acta Biomater2021https://conductscience.org/library/papers/33657451PubMed
33466312Tranexamic Acid Promotes Murine Bone Marrow-Derived Osteoblast Proliferation and Inhibits Osteoclast Formation In Vitro.Int J Mol Sci2021https://conductscience.org/library/papers/33466312PubMed
33081124Metabolomic Associations with Serum Bone Turnover Markers.Nutrients2020https://conductscience.org/library/papers/33081124PubMed
33007883Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging.Nutrients2020https://conductscience.org/library/papers/33007883PubMed
32987399The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.Endocrinology2020https://conductscience.org/library/papers/32987399PubMed
28370465Pharmacologic Calcitriol Inhibits Osteoclast Lineage Commitment via the BMP-Smad1 and IκB-NF-κB Pathways.J Bone Miner Res2017https://conductscience.org/library/papers/28370465PubMed
27050092Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis.PLoS One2016https://conductscience.org/library/papers/27050092PubMed
26424141Vitamin D and Clinical Outcomes in Dialysis.Semin Dial2015https://conductscience.org/library/papers/26424141PubMed
25931412
The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
Endocrine2015https://conductscience.org/library/papers/25931412PubMed
25446885Alterations in vitamin D metabolite, parathyroid hormone and fibroblast growth factor-23 concentrations in sclerostin-deficient mice permit the maintenance of a high bone mass.J Steroid Biochem Mol Biol2015https://conductscience.org/library/papers/25446885PubMed
24876121Reduced renal calcium excretion in the absence of sclerostin expression: evidence for a novel calcium-regulating bone kidney axis.J Am Soc Nephrol2014https://conductscience.org/library/papers/24876121PubMed
24605212Vitamin D endocrine system and osteoclasts.Bonekey Rep2014https://conductscience.org/library/papers/24605212PubMed
23566108Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.J Vet Emerg Crit Care (San Antonio)2013https://conductscience.org/library/papers/23566108PubMed
23411428Calcium absorption response to cholecalciferol supplementation in hemodialysis.Clin J Am Soc Nephrol2013https://conductscience.org/library/papers/23411428PubMed
22193236Vitamin D therapy in chronic kidney disease and end stage renal disease.Clin J Am Soc Nephrol2012https://conductscience.org/library/papers/22193236PubMed
20495792Gene expression and distribution of key bone turnover markers in the callus of estrogen-deficient, vitamin D-depleted rats.Calcif Tissue Int2010https://conductscience.org/library/papers/20495792PubMed

See all 133 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4333399

GET https://conductscience.org/api/papers/v1/4333399/cited_by?page=2